LifeVantage announced it has entered into a definitive agreement to acquire LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions.
The acquisition aligns perfectly with LifeVantage’s differentiation of activating optimal health processes throughout the body, helping your body make the things it needs for health including antioxidants and collagen, the company said. LoveBiome’s expertise in microbiome science complements LifeVantage’s existing portfolio of scientifically validated activators, including the flagship Protandim family of products and the MindBody GLP-1 System.
“This strategic acquisition represents an acceleration of our mission to offer people around the world a better path to wellness and a healthy vibrant life while also serving as a natural expansion of our Activation philosophy,” said Steve Fife, President and CEO of LifeVantage. “Kelly Olsen and his team have championed the direct sales industry, while innovating in a growing wellness category. We are thrilled to partner with LoveBiome and grow our reach. By combining their innovative microbiome solutions with our proven activation technologies, we’re able to activate wellness, both financial and physical, to a broader base of consumers.”*
“We are excited to join forces with LifeVantage and help entrepreneurs around the world love life with the very best compensation plan, products, and community in the industry,” said Kelly Olsen, founder and CEO of LoveBiome.
Compelling Strategic Rationale:
- Growth of LifeVantage Consultant network in key markets including the US, Taiwan, and Europe
- Strengthened position in direct sales industry with engaged leaders, broadened community reach
- Expanded product portfolio with Activation differentiation in gut and microbiome health
- Global gut health supplement market is projected to grow from $14.4 billion in 2025 to $32.4 billion by 2035, registering a robust CAGR of 8.4%**
- Enhances revenue growth and is expected to be accretive to Adjusted EPS and Adjusted EBITDA in year one with additional synergy opportunity
Under the terms of the definitive agreement, LifeVantage will acquire LoveBiome’s critical operating assets that are essential to the microbiome health business. The transaction structure includes the retention of key LoveBiome personnel, with founder and CEO Kelly Olsen, and other team members joining LifeVantage to ensure continuity of operations and leverage their expertise in the direct sales channel. The acquisition is expected to close by mid-October upon satisfaction of customary closing conditions and regulatory requirements.